Archives
-
o2h Ventures makes an SEIS Investment into Five Alarm Bio to strengthen anti-ageing science
28 February, 2023
-
Exciting news as o2h Ventures’ portfolio company Small Pharma, unveils positive top-line results of their Phase IIa clinical trial for treating MDD
31 January, 2023
-
o2h Ventures backed Kuano wins Innovate UK funding for designing the next generation of cancer drugs
18 January, 2023
-
o2h Ventures invests in Qkine – once again…
22 December, 2022
-
o2h Ventures backed Turbine raises €20 Million
30 November, 2022
-
Alevin Therapeutics won the Best Biotech Start-up at the OBN Awards 2022
18 November, 2022
-
o2h Ventures backed Neurofenix raises $7 Million to transform stroke and brain injury recovery
06 September, 2022
-
Funding boost for spin-out developing new medicines for life-threatening diseases
29 July, 2022
-
o2h Ventures makes an SEIS investment into CardiaTec
06 July, 2022